Page last updated: 2024-08-23

colforsin and 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol

colforsin has been researched along with 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's3 (42.86)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaminski, NE1
Guzmán, M; Sánchez, C; Velasco, G1
Bonhaus, DW; Chang, LK; Kwan, J; Martin, GR1
Song, ZH; Zhou, D1
Cristino, L; De Petrocellis, L; Di Marzo, V; Marini, P; Matias, I; Moriello, AS; Nigam, S; Starowicz, K1
Bosier, B; Hermans, E; Lambert, DM1
Kumar, P; Song, ZH1

Other Studies

7 other study(ies) available for colforsin and 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol

ArticleYear
Evidence for a cannabinoid receptor in immunomodulation by cannabinoid compounds.
    Advances in experimental medicine and biology, 1993, Volume: 335

    Topics: Adenylyl Cyclases; Animals; Cannabinoids; Cells, Cultured; Colforsin; Cyclohexanols; Dronabinol; Female; Immunity; Immunoglobulin M; Mice; Receptors, Cannabinoid; Receptors, Drug; Spleen; Stereoisomerism

1993
Metabolic stimulation of mouse spleen lymphocytes by low doses of delta9-tetrahydrocannabinol.
    Life sciences, 1997, Volume: 60, Issue:19

    Topics: Animals; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Dronabinol; Female; Glucose; In Vitro Techniques; Lymphocytes; Mice; Mice, Inbred BALB C; Oxidation-Reduction; Pertussis Toxin; Phospholipids; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Spleen; Virulence Factors, Bordetella

1997
Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:3

    Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Arachidonic Acids; Benzoxazines; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Cyclohexanols; Dronabinol; Endocannabinoids; Enzyme Activation; Humans; Morpholines; Naphthalenes; Polyunsaturated Alkamides; Receptors, Cannabinoid; Receptors, Drug; Signal Transduction; Transfection

1998
CB1 cannabinoid receptor-mediated neurite remodeling in mouse neuroblastoma N1E-115 cells.
    Journal of neuroscience research, 2001, Aug-15, Volume: 65, Issue:4

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antisense Elements (Genetics); Cannabinoids; Colforsin; Dronabinol; Gene Expression; Mice; Neurites; Neuroblastoma; Receptors, Cannabinoid; Receptors, Drug; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured

2001
Mechanisms for the coupling of cannabinoid receptors to intracellular calcium mobilization in rat insulinoma beta-cells.
    Experimental cell research, 2007, Aug-15, Volume: 313, Issue:14

    Topics: Animals; Arachidonic Acids; Bombesin; Calcium; Cannabinoids; Capsaicin; Cell Line, Tumor; Colforsin; Dose-Response Relationship, Drug; Dronabinol; Enzyme Inhibitors; Estrenes; Insulinoma; Neuroprotective Agents; Neurotransmitter Agents; Pertussis Toxin; Phosphoinositide Phospholipase C; Pyrrolidinones; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sensory System Agents; Signal Transduction; Thapsigargin; TRPV Cation Channels

2007
Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression.
    Biochemical pharmacology, 2009, Jan-15, Volume: 77, Issue:2

    Topics: Adenylyl Cyclases; Animals; Cannabinoid Receptor Modulators; Cannabinoids; Cell Line, Tumor; Colforsin; Cyclohexanols; DNA Primers; Dronabinol; Enzyme Activation; Excitatory Amino Acid Antagonists; Genes, Reporter; Luciferases; Mice; Neuroblastoma; Pertussis Toxin; Polymerase Chain Reaction; Receptor, Cannabinoid, CB1; Tetradecanoylphorbol Acetate; Transcription, Genetic; Transfection; Tyrosine 3-Monooxygenase

2009
Identification of raloxifene as a novel CB2 inverse agonist.
    Biochemical and biophysical research communications, 2013, May-24, Volume: 435, Issue:1

    Topics: Benzoxazines; Binding, Competitive; Bone Density Conservation Agents; Colforsin; Cyclic AMP; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Drug Approval; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Morpholines; Naphthalenes; Raloxifene Hydrochloride; Receptor, Cannabinoid, CB2; Transfection; Tritium; United States; United States Food and Drug Administration

2013